% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Joshi:162686,
author = {Joshi, Pranav and Riffel, Florian and Kumar, Sathish and
Villacampa, Nàdia and Theil, Sandra and Parhizkar, Samira
and Haass, Christian and Colonna, Marco and Heneka, Michael
and Arzberger, Thomas and Herms, Jochen and Walter, Jochen},
title = {{TREM}2 modulates differential deposition of modified and
non-modified {A}β species in extracellular plaques and
intraneuronal deposits.},
journal = {Acta Neuropathologica Communications},
volume = {9},
number = {1},
issn = {2051-5960},
address = {London},
publisher = {Biomed Central},
reportid = {DZNE-2021-01343},
pages = {168},
year = {2021},
note = {CC BY},
abstract = {Progressive accumulation of Amyloid-β (Aβ) deposits in
the brain is a characteristic neuropathological hallmark of
Alzheimer's disease (AD). During disease progression,
extracellular Aβ plaques undergo specific changes in their
composition by the sequential deposition of different
modified Aβ species. Microglia are implicated in the
restriction of amyloid deposits and play a major role in
internalization and degradation of Aβ. Recent studies
showed that rare variants of the Triggering Receptor
Expressed on Myeloid cells 2 (TREM2) are associated with an
increased risk for AD. Post-translational modifications of
Aβ could modulate the interaction with TREM2, and the
uptake by microglia. Here, we demonstrate that genetic
deletion of TREM2 or expression of a disease associated
TREM2 variant in mice lead to differential accumulation of
modified and non-modified Aβ species in extracellular
plaques and intraneuronal deposits. Human brains with rare
TREM2 AD risk variants also showed altered deposition of
modified Aβ species in the different brain lesions as
compared to cases with the common variant of TREM2. These
findings indicate that TREM2 plays a critical role in the
development and the composition of Aβ deposits, not only in
extracellular plaques, but also intraneuronally, that both
could contribute to the pathogenesis of AD.},
keywords = {Aged / Aged, 80 and over / Alzheimer Disease: pathology /
Amyloid beta-Peptides: chemistry / Amyloid beta-Peptides:
metabolism / Animals / Female / Humans / Male / Membrane
Glycoproteins: genetics / Membrane Glycoproteins: metabolism
/ Mice / Neurons: pathology / Plaque, Amyloid: chemistry /
Plaque, Amyloid: pathology / Receptors, Immunologic:
genetics / Receptors, Immunologic: metabolism / Aβ (Other)
/ Intraneuronal (Other) / Microglia (Other) /
Post-translational modification (Other) / TREM2 (Other) /
Vascular deposits (Other)},
cin = {AG Haass / Biomarker / AG Herms / Neuropathology /
Brainbank},
ddc = {610},
cid = {I:(DE-2719)1110007 / I:(DE-2719)1011301 /
I:(DE-2719)1110001 / I:(DE-2719)1140013},
pnm = {352 - Disease Mechanisms (POF4-352) / 353 - Clinical and
Health Care Research (POF4-353)},
pid = {G:(DE-HGF)POF4-352 / G:(DE-HGF)POF4-353},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:34663480},
pmc = {pmc:PMC8522217},
doi = {10.1186/s40478-021-01263-x},
url = {https://pub.dzne.de/record/162686},
}